Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

Authors: Hatsue Fujino, Mio Tanaka, Michio Imamura, Kei Morio, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Tomokazu Kawaoka, Shoichi Takahashi, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, Hiroshi Aikata, C. Nelson Hayes, Kazuaki Chayama

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Pruritus is a common symptom seen in patients with chronic liver disease. However, frequency and severity of pruritus in patients with chronic liver disease is unclear. We investigated frequency, severity and predictive factors of pruritus in these patients from a large cohort.

Methods

A total of 2477 patients with chronic liver disease without allergies or skin diseases were investigated for itch frequency and severity. Itch severity was self-assessed using pruritus scores using the numerical rating scale (NRS). Multivariate regression analysis was performed to identify factors associated with pruritus. Serum autotaxin levels were measured in patients with primary biliary cholangitis (PBC), and the relationship to liver fibrosis and pruritus was analyzed.

Results

The frequency of pruritus in patients with chronic liver disease was significantly higher than in subjects without liver disease (29.8 and 16.2%, respectively, P < 0.001). NRS was high in patients with chronic liver disease, especially in those with PBC, as is generally expected. Multivariate analysis identified lower albumin, higher eosinophil count, and etiology of PBC as independent factors associated with severe pruritus (≥5 points of NRS). In patients with PBC, serum autotaxin levels were significantly correlated with liver fibrosis markers such as platelet count and liver stiffness, and hepatobiliary enzymes such as total bilirubin, aspartate aminotransferase and alkaline phosphatase. However, no significant correlations between serum autotaxin levels and frequency and severity of pruritus were observed in patients with PBC.

Conclusion

The frequency of pruritus was high in patients with chronic liver disease. Reduction of liver function is associated with severe pruritus based on the large number of patients with chronic liver disease. Serum autotaxin is useful for assessing liver fibrosis and severity of cholangitis; however, it is not a predictive marker for severe pruritus in patients with PBC.
Literature
1.
go back to reference Greaves MW, Wall PD. Pathophysiology of itching. Lancet. 1996;348:938–40.CrossRef Greaves MW, Wall PD. Pathophysiology of itching. Lancet. 1996;348:938–40.CrossRef
2.
go back to reference Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003;7:879–900.CrossRef Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003;7:879–900.CrossRef
3.
go back to reference Younossi ZM, Kiwi ML, Boparai N, et al. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol. 2000;95:497–502.CrossRef Younossi ZM, Kiwi ML, Boparai N, et al. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol. 2000;95:497–502.CrossRef
4.
go back to reference Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology. 1999;29:1003–6.CrossRef Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology. 1999;29:1003–6.CrossRef
5.
go back to reference Umeuchi H, Togashi Y, Honda T, et al. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003;477:29–35.CrossRef Umeuchi H, Togashi Y, Honda T, et al. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003;477:29–35.CrossRef
6.
go back to reference Bergasa NV. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Med Hypotheses. 2018;110:86–9.CrossRef Bergasa NV. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Med Hypotheses. 2018;110:86–9.CrossRef
7.
go back to reference Pan ZZ. mu-opposing actions of kappa-opioid receptor. Trens Pharmacol Sci. 1998;19:94–8.CrossRef Pan ZZ. mu-opposing actions of kappa-opioid receptor. Trens Pharmacol Sci. 1998;19:94–8.CrossRef
8.
go back to reference Kumada H, Miyakawa H, Muramatsu T, et al. Efficacy of nalfurafine hydrochloride in patient with chronic liver disease with refractory pruritus: A randomized double-blind trial. Hepatol Res. 2017;47:972–82.CrossRef Kumada H, Miyakawa H, Muramatsu T, et al. Efficacy of nalfurafine hydrochloride in patient with chronic liver disease with refractory pruritus: A randomized double-blind trial. Hepatol Res. 2017;47:972–82.CrossRef
9.
go back to reference Stracke ML, Krutzsch HC, Unsworth EJ, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem. 1992;267:2524–9.PubMed Stracke ML, Krutzsch HC, Unsworth EJ, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem. 1992;267:2524–9.PubMed
10.
go back to reference Tokumura A, Majima E, Kariya Y, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002;277:39436–39,442.CrossRef Tokumura A, Majima E, Kariya Y, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002;277:39436–39,442.CrossRef
11.
go back to reference Yamazaki T, Joshita S, Umemura T, et al. Association of Serum autotaxin levels with liver fibrosis in patients with chronic hepatitis C. Sci Rep. 2017;7:46705.CrossRef Yamazaki T, Joshita S, Umemura T, et al. Association of Serum autotaxin levels with liver fibrosis in patients with chronic hepatitis C. Sci Rep. 2017;7:46705.CrossRef
12.
go back to reference Nakagawa H, Ikeda H, Nakamura K, et al. Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta. 2011;412:1201–6.CrossRef Nakagawa H, Ikeda H, Nakamura K, et al. Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta. 2011;412:1201–6.CrossRef
13.
go back to reference Joshita S, Ichikawa Y, Umemura T, et al. Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatol Res. 2018;48:275–85.CrossRef Joshita S, Ichikawa Y, Umemura T, et al. Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatol Res. 2018;48:275–85.CrossRef
14.
go back to reference Fujimori N, Umemura T, Kimura T, et al. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2018;24:1239–49.CrossRef Fujimori N, Umemura T, Kimura T, et al. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2018;24:1239–49.CrossRef
15.
go back to reference Joshita S, Umemura T, Usami Y, et al. Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis. Sci Rep. 2018;8:8159.CrossRef Joshita S, Umemura T, Usami Y, et al. Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis. Sci Rep. 2018;8:8159.CrossRef
16.
go back to reference Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008–18.CrossRef Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008–18.CrossRef
17.
go back to reference Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2016;43:1317–25.CrossRef Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2016;43:1317–25.CrossRef
18.
go back to reference Ständer S, Augustin M, Reich A, et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol. 2013;93:509–14.CrossRef Ständer S, Augustin M, Reich A, et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol. 2013;93:509–14.CrossRef
19.
go back to reference Nakamura K, Igarashi K, Ide K, et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta. 2008;388:51–8.CrossRef Nakamura K, Igarashi K, Ide K, et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta. 2008;388:51–8.CrossRef
20.
go back to reference Wunsch E, Krawczyk M, Milkiewicz M, et al. Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver Diseases. Sci Rep. 2016;6:30847.CrossRef Wunsch E, Krawczyk M, Milkiewicz M, et al. Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver Diseases. Sci Rep. 2016;6:30847.CrossRef
21.
go back to reference Oeda S, Takahashi H, Yoshida H, et al. Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res. 2018;48:E252–62.CrossRef Oeda S, Takahashi H, Yoshida H, et al. Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res. 2018;48:E252–62.CrossRef
22.
go back to reference Lebovics E, Seif F, Kim D, et al. Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities. Dig Dis Sci. 1997;42:1094–9.CrossRef Lebovics E, Seif F, Kim D, et al. Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities. Dig Dis Sci. 1997;42:1094–9.CrossRef
23.
go back to reference Tachi Y, Hirai T, Kojima Y, et al. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response. Eur J Gastroenterol Hepatol. 2018;30:1066–72.CrossRef Tachi Y, Hirai T, Kojima Y, et al. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response. Eur J Gastroenterol Hepatol. 2018;30:1066–72.CrossRef
24.
go back to reference Bonacini M. Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections. Dig Liver Dis. 2000;32:621–5.CrossRef Bonacini M. Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections. Dig Liver Dis. 2000;32:621–5.CrossRef
25.
go back to reference Rishe E, Azarm A, Bergasa NV. Itch in primary biliary cirrhosis: a patients’ perspective. Acta Derm Venereol. 2008;88:34–7.CrossRef Rishe E, Azarm A, Bergasa NV. Itch in primary biliary cirrhosis: a patients’ perspective. Acta Derm Venereol. 2008;88:34–7.CrossRef
26.
go back to reference Bhalerao A, Mannu GS. Management of pruritus in chronic liver disease. Dermatol Res Pract. 2015;2015:295891.CrossRef Bhalerao A, Mannu GS. Management of pruritus in chronic liver disease. Dermatol Res Pract. 2015;2015:295891.CrossRef
27.
go back to reference Akuta N, Kumada H, Fujiyama S, et al. Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochloride. Hepatol Res. 2018;48:45–50.CrossRef Akuta N, Kumada H, Fujiyama S, et al. Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochloride. Hepatol Res. 2018;48:45–50.CrossRef
28.
go back to reference Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–73.CrossRef Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–73.CrossRef
29.
go back to reference Newton JL, Bhala N, Burt J, Jones DE. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol. 2006;44:776–83.CrossRef Newton JL, Bhala N, Burt J, Jones DE. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol. 2006;44:776–83.CrossRef
Metadata
Title
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis
Authors
Hatsue Fujino
Mio Tanaka
Michio Imamura
Kei Morio
Atsushi Ono
Takashi Nakahara
Eisuke Murakami
Tomokazu Kawaoka
Shoichi Takahashi
Daiki Miki
Masataka Tsuge
Akira Hiramatsu
Hiroshi Aikata
C. Nelson Hayes
Kazuaki Chayama
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1092-z

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue